Beijing Beilu Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Beijing Beilu Pharmaceutical Co., Ltd. was established in September 1992. The company is mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise and one of the first batch of listed companies on the Growth Enterprise Market (stock code 300016). The company developed and launched contrast agent products in the early stage in China. After more than 20 years of industry exploration and professional accumulation, it has formed a unique core competitive advantage in this field and is a leading enterprise in the domestic contrast agent industry. The company is also increasing research and development efforts in the fields of central nervous system and endocrine drugs, striving to achieve product diversification. The company's Miyun Pharmaceutical Factory has established a production line for contrast agent products designed according to EU standards. The workshop adopts international advanced equipment and design concepts to ensure that product quality meets international standards. At the same time, in order to implement the national integrated development strategy of Beijing Tianjin Hebei, the company has built a traditional Chinese medicine extraction and raw material drug production base in Bohai New Area, Cangzhou City, Hebei Province, achieving the layout of the industrial chains in Beijing and Cangzhou. In 2020, Zhejiang Haichang Pharmaceutical Co., Ltd. became a holding subsidiary, further consolidating the company's integrated business model of "raw materials+preparations" for comparative agent products. In the future, the company will continue to consolidate its leading position in the contrast agent market, strive to build a corporate brand, achieve product diversification, and create long-term and sustained value growth and performance returns for customers and investors. |
| Headquarter | Beijing |
| Establish Date | 9/5/1992 |
| Listed Code | 300016.SZ |
| Listed Date | 10/30/2009 |
| Chairman | Wang Xu. |
| CEO | Wang Xu. |
| Website | www.beilu.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
